Wnt/β-Catenin Signaling Is a Therapeutic Target in Anaplastic Thyroid Carcinoma

Scientists identified whether Wnt inhibitors could be potential therapeutic agents for anaplastic thyroid carcinoma (ATC) patients with limited treatment options. They used 4 ATC spheroid cell lines and two primary patient-derived ATC organoid cultures.